|
| Commodity | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 |
| Antisera & oth. blood fractions & modified immunological prods., whether or ... | $85,197,000 | $99,649,000 | $99,253,000 | $169,028,000 | $155,560,000 | $173,839,000 | $321,383,000 |
| Vaccines for human medicine | $16,328,000 | $20,673,000 | $30,954,000 | $49,374,000 | $47,874,000 | $60,454,000 | $72,855,000 |
| Human blood; animal blood prepd. for therapeutic/prophylactic/diagnostic us ... | $13,431,000 | $12,881,000 | $16,455,000 | $20,647,000 | $15,440,000 | $14,475,000 | $22,903,000 |
| Total | $114,956,000 | $133,203,000 | $146,662,000 | $239,049,000 | $218,874,000 | $248,768,000 | $417,141,000 |
|
|
